BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26468141)

  • 21. Successful Mercaptopurine Usage despite Azathioprine-Induced Pancreatitis in Paediatric Crohn's Disease.
    Gallego-Gutiérrez S; Navas-López VM; Kolorz M; Bartosova L; Lukac K; Luque-Pérez S; Núñez-Caro L; García-Galán P; Fernández-Crehuet FG; Blasco-Alonso J; Serrano-Nieto MJ; Sierra-Salinas C
    J Crohns Colitis; 2015 Aug; 9(8):676-9. PubMed ID: 25968582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recurrent acute pancreatitis induced by 5-ASA and azathioprine in ulcerative colitis.
    Hegyi PJ; Szakács Z; Faluhelyi N; Németh BC; Bajor J; Hegyi P;
    Pancreatology; 2020 Dec; 20(8):1656-1660. PubMed ID: 33250090
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DQA1-HLA-DRB1 polymorphism is a major predictor of azathioprine-induced pancreatitis in patients with inflammatory bowel disease.
    Wilson A; Jansen LE; Rose RV; Gregor JC; Ponich T; Chande N; Khanna R; Yan B; Jairath V; Khanna N; Sey M; Beaton M; McIntosh K; Teft WA; Kim RB
    Aliment Pharmacol Ther; 2018 Mar; 47(5):615-620. PubMed ID: 29270995
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
    Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
    Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HLA variants associated with azathioprine-induced pancreatitis in patients with Crohn's disease.
    Ås J; Bertulyte I; Eriksson N; Magnusson PKE; Wadelius M; Hallberg P
    Clin Transl Sci; 2022 May; 15(5):1249-1256. PubMed ID: 35120281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inflammatory Bowel Disease and Pancreatitis: A Review.
    Ramos LR; Sachar DB; DiMaio CJ; Colombel JF; Torres J
    J Crohns Colitis; 2016 Jan; 10(1):95-104. PubMed ID: 26351384
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effective maintenance of inflammatory bowel disease remission by azathioprine does not require concurrent 5-aminosalicylate therapy.
    Campbell S; Ghosh S
    Eur J Gastroenterol Hepatol; 2001 Nov; 13(11):1297-301. PubMed ID: 11692054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute pancreatitis after azathioprine treatment for ulcerative colitis.
    Tragnone A; Bazzocchi G; Aversa G; Pecorelli MG; Elmi G; Venerato S; Lanfranchi GA
    Ital J Gastroenterol; 1996; 28(2):102-4. PubMed ID: 8782004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A trial of mercaptopurine is a safe strategy in patients with inflammatory bowel disease intolerant to azathioprine: an observational study, systematic review and meta-analysis.
    Kennedy NA; Rhatigan E; Arnott ID; Noble CL; Shand AG; Satsangi J; Lees CW
    Aliment Pharmacol Ther; 2013 Nov; 38(10):1255-66. PubMed ID: 24117596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
    Kakuta Y; Naito T; Onodera M; Kuroha M; Kimura T; Shiga H; Endo K; Negoro K; Kinouchi Y; Shimosegawa T
    Pharmacogenomics J; 2016 Jun; 16(3):280-5. PubMed ID: 26076924
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thiopurine methyltransferase activity influences clinical response to azathioprine in inflammatory bowel disease.
    Cuffari C; Dassopoulos T; Turnbough L; Thompson RE; Bayless TM
    Clin Gastroenterol Hepatol; 2004 May; 2(5):410-7. PubMed ID: 15118980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bone density improves with disease remission in patients with inflammatory bowel disease.
    Reffitt DM; Meenan J; Sanderson JD; Jugdaohsingh R; Powell JJ; Thompson RP
    Eur J Gastroenterol Hepatol; 2003 Dec; 15(12):1267-73. PubMed ID: 14624148
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased rates of early adverse reaction to azathioprine in patients with Crohn's disease compared to autoimmune hepatitis: a tertiary referral center experience.
    Bajaj JS; Saeian K; Varma RR; Franco J; Knox JF; Podoll J; Emmons J; Levy M; Binion DG
    Am J Gastroenterol; 2005 May; 100(5):1121-5. PubMed ID: 15842588
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Azathioprine in chronic inflammatory bowel diseases. Evidence base].
    Herrlinger K; Stange EF
    Med Klin (Munich); 2000 Apr; 95(4):201-6. PubMed ID: 10808301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pretreatment HLADQA1-HLADRB1 Testing for the Prevention of Azathioprine-Induced Pancreatitis in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Wilson A; Wang Q; Choi YH; Ponich T; Gregor JC; Chande N; Yan B; Sey M; Beaton M; Kim RB
    Clin Transl Gastroenterol; 2021 Apr; 12(4):e00332. PubMed ID: 33821842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The efficacy of azathioprine for the treatment of inflammatory bowel disease: a 30 year review.
    Fraser AG; Orchard TR; Jewell DP
    Gut; 2002 Apr; 50(4):485-9. PubMed ID: 11889067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
    Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
    Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.